Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 168960, 7 pages
http://dx.doi.org/10.1155/2014/168960
Research Article

Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer

1Department of Thoracic Surgery, Fudan University Shanghai Cancer Center (FUSCC), Shanghai 200032, China
2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
3Department of Radiation Oncology, Kimmel Cancer Center and Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
4Department of Biostatistics, Public Health School, Fudan University, Shanghai 200032, China
5Department of Pathology, Fudan University Shanghai Cancer Center (FUSCC), Shanghai 200032, China
6Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, China

Received 21 September 2014; Revised 24 November 2014; Accepted 25 November 2014; Published 10 December 2014

Academic Editor: Yi-Chia Huang

Copyright © 2014 Wei Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Besharat, A. Jabbari, S. Semnani, A. Keshtkar, and J. Marjani, “Inoperable esophageal cancer and outcome of palliative care,” World Journal of Gastroenterology, vol. 14, no. 23, pp. 3725–3728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Thompson, A. R. Ruszkiewicz, G. G. Jamieson et al., “Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens,” Annals of Surgical Oncology, vol. 15, no. 12, pp. 3447–3458, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. I. P. Trougakos and E. S. Gonos, “Clusterin/apolipoprotein J in human aging and cancer,” The International Journal of Biochemistry & Cell Biology, vol. 34, no. 11, pp. 1430–1448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Ma and H.-C. Li, “Advances in research on the role of clusterin in treatment of human malignancies,” Tumor, vol. 33, no. 4, pp. 368–371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Shannan, M. Seifert, K. Leskov et al., “Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer,” Cell Death and Differentiation, vol. 13, no. 1, pp. 12–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Peat and B. Barton, Medical Statistics: A Guide to Data Analysis and Critical Appraisal, Blackwell Publishing, Oxford, UK, 2005.
  8. C.-R. Yang, K. Leskov, K. Hosley-Eberlein et al., “Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 11, pp. 5907–5912, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Scaltriti, A. Santamaria, R. Paciucci, and S. Bettuzzi, “Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells,” Cancer Research, vol. 64, no. 17, pp. 6174–6182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Debure, J.-L. Vayssière, V. Rincheval, F. Loison, Y. Le Drŕean, and D. Michel, “Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration,” Journal of Cell Science, vol. 116, no. 15, pp. 3109–3121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Rodrguez-Pieiro, A. Garca-Lorenzo, S. Blanco-Prieto et al., “Secreted clusterin in colon tumor cell models and its potentialas diagnostic marker for colorectal cancer,” Cancer Investigation, vol. 30, no. 1, pp. 72–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. V. July, E. Beraldi, A. So et al., “Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo,” Molecular Cancer Therapeutics, vol. 3, no. 3, pp. 223–232, 2004. View at Google Scholar · View at Scopus
  13. M. Redondo, T. Tellez, and M. J. Roldan, “The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas,” Advances in Cancer Research, vol. 105, pp. 21–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Zhu, T. Tran, J. M. Rukstalis, P. Sun, B. Damsz, and S. F. Konieczny, “Inhibition of Mist 1 homodimer formation induces pancreatic acinar -to-ductal metaplasia,” Molecular and Cellular Biology, vol. 24, no. 7, pp. 2673–2681, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-Z. He, Z.-M. Song, K. Wang et al., “Alterations in expression, proteolysis and intracellular localizations of clusterin in esophageal squamous cell carcinoma,” World Journal of Gastroenterology, vol. 10, no. 10, pp. 1387–1391, 2004. View at Google Scholar · View at Scopus
  16. L.-R. He, M.-Z. Liu, B.-K. Li et al., “Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma,” Cancer Science, vol. 100, no. 12, pp. 2354–2360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-Y. Zhang, W.-T. Ying, Y.-S. Mao et al., “Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches,” World Journal of Gastroenterology, vol. 9, no. 4, pp. 650–654, 2003. View at Google Scholar · View at Scopus
  18. X. Luo, M. Suzuki, A. S. Ghandhi et al., “ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence,” PloS One, vol. 9, no. 6, Article ID e99983, 2014. View at Google Scholar
  19. Q. Yu and I. Stamenkovic, “Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis,” Genes and Development, vol. 14, no. 2, pp. 163–176, 2000. View at Google Scholar · View at Scopus
  20. S. Zucker, R. M. Lysik, M. H. Zarrabi, and U. Moll, “Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer,” Cancer Research, vol. 53, no. 1, pp. 140–146, 1993. View at Google Scholar · View at Scopus
  21. X. Wang, L. Luo, D. Dong, Q. Yu, and K. Zhao, “Clusterin plays an important role in clear renal cell cancer metastasis,” Urologia Internationalis, vol. 92, no. 1, pp. 95–103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Pucci, E. Bonanno, F. Sesti et al., “Clusterin in stool: a new biomarker for colon cancer screening?” The American Journal of Gastroenterology, vol. 104, no. 11, pp. 2807–2815, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Xie, J. S. T. Sham, W.-F. Zeng et al., “Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression,” World Journal of Gastroenterology, vol. 11, no. 21, pp. 3285–3289, 2005. View at Google Scholar · View at Scopus
  24. T. Chen, J. Turner, S. McCarthy, M. Scaltriti, S. Bettuzzi, and T. J. Yeatman, “Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent,” Cancer Research, vol. 64, no. 20, pp. 7412–7419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Pucci, E. Bonanno, F. Pichiorri, C. Angeloni, and L. G. Spagnoli, “Modulation of different clusterin isoforms in human colon tumorigenesis,” Oncogene, vol. 23, no. 13, pp. 2298–2304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Carnevali, F. Luppi, D. D'Arca et al., “Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke,” The American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 4, pp. 393–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Park, K. W. Mathis, and I. K. Lee, “The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases,” Reviews in Endocrine and Metabolic Disorders, vol. 15, no. 1, pp. 45–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Daimon, T. Oizumi, S. Karasawa et al., “Association of the clusterin gene polymorphisms with type 2 diabetes mellitus,” Metabolism: Clinical and Experimental, vol. 60, no. 6, pp. 815–822, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K.-W. Jung, S. Park, A. Shin et al., “Do female cancer patients display better survival rates compared with males? Analysis of the Korean national registry data, 2005–2009,” PLoS ONE, vol. 7, no. 12, Article ID e52457, 2012. View at Publisher · View at Google Scholar · View at Scopus